Plasma is the yellowish liquid part of human blood which accounts for 55% of the total blood volume. Plasma is composed mostly of water (90-92%) but also contains a small amount of other substances including a range of vital proteins. These proteins are used to produce plasma-derived medicinal products (PDMPs) that are essential to treat a variety of life-threatening rare plasma related disorders. Such proteins include immunoglobulins, coagulation factors, alpha-1 antitrypsin and albumin among others.
In order to produce life-saving PDMPs, a sufficient amount of plasma, the raw material, is required. As demand for immunoglobulin therapies in particular has witnessed a continued growth for a number of years and is set to continue to surge, an increasing amount of plasma needs to be collected.